If there was ever a time for this pic, it’s now.
Bud’s official statement:
“Major League Baseball has worked diligently with the Players Association for more than a decade to make our Joint Drug Program the best in all of professional sports. I am proud of the comprehensive nature of our efforts – not only with regard to random testing, groundbreaking blood testing for human Growth Hormone and one of the most significant longitudinal profiling programs in the world, but also our investigative capabilities, which proved vital to the Biogenesis case. Upon learning that players were linked to the use of performance-enhancing drugs, we vigorously pursued evidence that linked those individuals to violations of our Program. We conducted a thorough, aggressive investigation guided by facts so that we could justly enforce our rules.
“Despite the challenges this situation has created during a great season on the field, we pursued this matter because it was not only the right thing to do, but the only thing to do. For weeks, I have noted the many players throughout the game who have strongly voiced their support on this issue, and I thank them for it. I appreciate the unwavering support of our owners and club personnel, who share my ardent desire to address this situation appropriately. I am also grateful to the Professional Baseball Athletic Trainers Society and our club physicians, who were instrumental in the banning of amphetamines and whose expertise remains invaluable to me. As an institution, we have made unprecedented strides together.
“It is important to point out that 16,000 total urine and blood tests were conducted on players worldwide under MLB Drug Programs in 2012. With the important additions of the hGH testing and longitudinal profiling this season, we are more confident than ever in the effectiveness of the testing program. Those players who have violated the Program have created scrutiny for the vast majority of our players, who play the game the right way.
“This case resoundingly illustrates that the strength of our Program is not limited only to testing. We continue to attack this issue on every front – from science and research, to education and awareness, to fact-finding and investigative skills. Major League Baseball is proud of the enormous progress we have made, and we look forward to working with the players to make the penalties for violations of the Drug Program even more stringent and a stronger deterrent.
“As a social institution with enormous social responsibilities, Baseball must do everything it can to maintain integrity, fairness and a level playing field. We are committed to working together with players to reiterate that performance-enhancing drugs will not be tolerated in our game.”
Jon Morosi of FOX Sports reports that the Tigers are in discussions with free agent starter Jordan Zimmermann. His sources have told him that the talks have become “serious”.
Zimmermann, 29, has a career 3.32 ERA across parts of seven seasons in the majors. He finished fifth in National League Cy Young Award balloting in 2014, finishing with a 2.66 ERA and a 182/29 K/BB ratio over 199 2/3 innings.
Among starters who have amassed at least 1,000 innings since 2009, only Cliff Lee, Dan Haren, Madison Bumgarner, and Zack Greinke have compiled a better strikeout-to-walk ratio than Zimmermann’s 4.09. While he doesn’t have the star power of other free agents such as Greinke or David Price, the Tigers would certainly improve their rotation by bringing him on board.
Having already added Jesse Chavez and J.A. Happ to the mix and re-signing Marco Estrada early in the offseason, Blue Jays interim GM Tony LaCava said the team will continue to pursue pitching upgrades, as Sportsnet’s Ben Nicholson-Smith reports. Nicholson-Smith added that LaCava declined to comment on free agent ace David Price. It is believed that the Jays will not pursue Price and other big-name free agent starting pitchers given their November activity.
The Jays re-signed Estrada to a two-year, $26 million deal on November 13, acquired Chavez from the Athletics in exchange for reliever Liam Hendriks on November 20 and signed Happ to a three-year, $36 million deal on Friday.
Nicholson-Smith notes in a column on Sportsnet that the Jays need to address the bullpen in particular. That is especially true after swapping Hendriks, who had a career-best 2.92 ERA out of the Jays’ bullpen in 2015, for a back-end starting pitcher.
Jon Heyman of CBS Sports spoke to an anonymous baseball executive, who said that Nationals closer Jonathan Papelbon is “untradeable”. The Nationals are hoping to trade both Papelbon and the man he displaced, Drew Storen.
Papelbon has a poor reputation in baseball, particularly after a dugout altercation with superstar outfielder Bryce Harper. Focusing strictly on what he does on the field, Papelbon still gets the job done. The 35-year-old finished the last season with a combined 2.13 ERA, 24 saves, and a 56/12 K/BB ratio over 63 1/3 innings between the Phillies and Nationals.
The Nationals owe Papelbon $11 million for the 2016 season.
Baseball America’s J.J. Cooper reports that corner infielder Mike Hessman has retired from professional baseball after 20 seasons. Hessman hit 433 home runs in the minor leagues, an all-time record. He broke Buzz Arlett’s record this past August and with style as #433 was a grand slam.
Hessman, 37, was selected in the 16th round of the 1996 draft by the Braves and remained with the organization through the 2004 season. He then went to the Tigers from 2005-09, the Mets in 2010, then drifted into the Astros and Reds’ farm systems before returning to the Tigers for the last two years.
Hessman took 250 plate appearances at the major league level, batting .188/.272/.422 with 14 home runs and 33 RBI.